Earnings

Beyond Air Shares Rise Intraday After Q3 FY2026 Revenue More Than Doubles; Loss Narrows on Cost Cuts

Beyond Air Shares Rise Intraday After Q3 FY2026 Revenue More Than Doubles; Loss Narrows on Cost Cuts

Beyond Air, Inc. (NASDAQ: XAIR) released strong Q3 FY2026 earnings. As a result, shares rose during intraday trading. Investors reacted…

Credicorp Shares Fall 2% After Q4 Earnings Miss Despite Record Full-Year Profit

Credicorp Ltd (NYSE: BAP) shares slid in early trading on results that missed Street expectations for the fourth quarter. BAP…

Enbridge Gains 4% as Q4 Earnings Top Estimates, Full-Year Cash Flow Climbs

Enbridge Inc. (NYSE: ENB) shares climbed in early trading after the Canadian pipeline operator reported fourth-quarter and full-year 2025 results…

Wendy’s shares tumble on weak 2026 outlook, U.S. sales slump

Shares of The Wendy’s Company (Nasdaq: WEN) fell 6.5% to $6.80 in Friday afternoon trading as the fast-food chain’s disappointing…

Cameco Shares Fall After Reporting Higher Q4 Profit and Strong Full-Year Growth

Shares of Cameco Corp. (NYSE: CCJ) were trading lower on Friday, slipping about 2.9% to $112.97 in midday New York…

GEE Group Inc. Narrows Q1 2026 Loss as Margin Expansion Offsets Revenue Contraction

GEE Group Inc. (NYSE American: JOB), a diversified provider of professional staffing and human resource solutions, announced its financial results…

Cooper Standard Reports Strong Q4 Revenue and Record EV Awards

Cooper-Standard Holdings Inc. (NYSE: CPS) reported its fourth-quarter and full-year 2025 financial results on February 12, 2026, revealing a complex…

Rithm Property Trust Marks 2025 Turnaround; Shifts Focus to Commercial Credit

Rithm Property Trust Inc. (NYSE: RPT), the externally managed real estate investment vehicle of Rithm Capital Corp., released its fourth-quarter…

Roku stock rises after Q4 FY25 earnings beat estimates; revenue up 16%

Roku, Inc. (NASDAQ: ROKU) has reported a double-digit growth in revenues for the fourth quarter of fiscal 2025. The media…

Vertex Pharma Q4 2025 Earnings Results

Vertex Pharmaceuticals reported solid financial results for the fourth quarter of 2025, driven by continued demand for its cystic fibrosis…